贝康医疗-B发布中期业绩 股东应占亏损1.21亿元 同比扩大1.31%

Core Viewpoint - Beikang Medical-B (02170) reported a decline in revenue and an increase in shareholder losses for the six months ending June 30, 2025, indicating financial challenges for the company [1] Financial Performance - The group's revenue was RMB 101 million, representing a year-on-year decrease of 18.76% [1] - Shareholder losses amounted to RMB 121 million, which is an increase of 1.31% compared to the previous year [1] - The loss per share was RMB 0.4 [1]